Immunoassay Market will reach USD 19.76 billion by 2025: Meticulous Research®

Immunoassay Market by Product (Kits and Reagents, Analyzers, Software), Platform (Chemiluminescence, Radioimmunoassays) Application (Infectious Diseases, Cardiology), End User (Hospitals, Academic Laboratories), and Geography - Global Forecast to 2025.

Immunoassays are used in healthcare industry in various diagnostic applications, including infectious diseases, endocrinology, oncology, bone & mineral disorders, cardiology, hematology & blood screening, autoimmune disorders, toxicology, and neonatal screening. Increasing incidence of chronic and infectious diseases, growing use of immunoassay in oncology, and rise in drug and alcohol testing are expected to drive the immunoassay market during the forecast period. Furthermore, immunoassay diagnostics are gaining higher attention from end users owing to its several advantages such as, high sensitivity, lower testing time, low limits of detection, high-throughput diagnosis, and inexpensive method. Subsequently, growing technological advancements in immunoassay are further expected to fuel the growth of immunoassay market over the coming years. Meticulous Research® in its latest publication on Immunoassay Market reveals that the global immunoassay market will increase at a CAGR of 5.9% from 2019 to 2025 to reach $19.76 billion by 2025.

The increase in the outbreaks of infectious diseases worldwide, and emerging economies such as Latin America, South East Asia, and Africa provides significant growth opportunities to the manufacturers operating in the global immunoassay market. However, limitations of immunoassays and development of alternative technologies are some of the key factors that may hinder the adoption of immunoassay products.

Get Free Sample Copy of Immunoassay Market Report at:

To provide efficient analysis, Meticulous Research® has segmented this market on the basis of product (immunoassay kits & reagents, immunoassay analyzers, immunoassay software & services), platforms (chemiluminescence immunoassays, fluorescence immunoassays, colorimetric immunoassays, radioimmunoassays, other platforms) application (infectious diseases, cardiology, endocrinology, oncology, bone & mineral disorders, autoimmune disorders, allergy, other applications), end user (hospitals & clinics, clinical laboratories/reference labs, blood banks, pharmaceutical and biotechnology companies, research & academic laboratories, other end users), and geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa).

In 2018, infectious diseases segment accounted for the largest share of the global immunoassay market, by application. The largest share of this segment is mainly attributed to rising incidence of infectious diseases and growing adoption of immunoassay diagnostics in the management of infectious diseases.

Geographic Review
Geographically, North America commanded the largest share in this market followed by Europe. Asia Pacific region is expected to grow at the higher CAGR during the forecast period. The immunoassays market in Asia Pacific region, especially in China and India, is expected to witness high growth during the forecast period. Growth in this market is expected to be driven by large pool of patient population, increasing prevalence of infectious diseases and cancer, increasing government spending on the healthcare, and improving accessibility to diagnosis and treatment services. In addition, favorable government policies and healthcare structural reform are further expected to drive the market growth.

Immunoassay Market Key Players:
The report provides competitive intelligence in terms of company overview, financials, growth strategies, product benchmarking, geographical presence, and market share analysis on some of the key market players including F. Hoffman La Roche AG (Switzerland), Abbott Laboratories (U.S.), Siemens AG (Germany), Danaher Corporation (U.S.), Sysmex Corporation (Japan), bioMérieux (France), Ortho Clinical Diagnostics (U.S.), DiaSorin SPA (Italy), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific (U.S.), Becton, Dickinson and Company (U.S.), Merck (Germany), Bio-Rad Laboratories (U.S.), Agilent Technologies (U.S.), PerkinElmer (U.S.), Quidel Corporation (U.S.), Bio-Techne Corporation (U.S.), and Mindray (China) among others.

Technological Advancements in Immunoassay
Immunoassays have been one of the fast-growing clinical diagnostics technologies over the years. The technological advancements in immunoassays driven by the need for early detection of diseases have supported their adoption over the years, and hence have supported the immunoassay market growth. Today, with the development of excellent methods of signal generation, the attention has shifted to the development of immunochemical methods and instruments to provide convenient high-performance systems. Important advances have been made in the design of immunochemical approaches that allow small molecules, such as drugs, metabolites and toxins, to substitute dynamic format assays with non-competitive formats, bringing advantages previously seen only with large molecular analytes. Bispecific antibodies and recombinant proteins are also beginning to provide an impact upon immunodiagnostics, with the promise of reagents which are even more particular. Through all these advances, the usage of immunoassays is further expected to expand, in turn supporting the market growth.

Browse Full Research Report with TOC at:

Table Of Contents
1. Introduction
1.1. Market Definition
1.2. Market Segmentation
1.3. Currency and Limitations
1.3.1. Currency
1.3.2. Limitations
1.4. Key Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
2.1.3. Market Size Estimation

3. Executive Summary
3.1. Introduction
3.2. Market Dynamics
3.3. Product Segment Analysis
3.4. Platforms Segment Analysis
3.5. Application Analysis
3.6. End User Analysis
3.7. Regional Analysis
3.8. Competitive Analysis

4. Market Insights
4.1. Market Overview
4.2. Drivers
4.2.1. Increasing Incidence of Chronic Diseases and Infectious Diseases
4.2.2. Increasing Use of Immunoassays in Oncology
4.2.3. Vital Role of Immunoassays in Drug and Alcohol Testing
4.2.4. Technological Advancements in Immunoassay
4.3. Restraints
4.3.1. Limitations of Immunoassay
4.4. Opportunities
4.4.1. Growth Opportunities in Emerging Economies
4.4.2. Increasing Epidemic Potentials

5. Global Immunoassay Market, by Product
5.1. Overview
5.2. Immunoassay Kits and Reagents
5.2.1. Rapid Test Kits and Reagents
5.2.2. Elisa Kits and Reagents
5.2.3. Western Blot Kits and Reagents
5.2.4. Elispot Kits and Reagents
5.2.5. Other Immunoassay Kits and Reagents
5.3. Immunoassay Analyzers
5.4. Immunoassay Software and Services

6. Global Immunoassay Market, by Platforms
6.1. Overview
6.2. Chemiluminescence Immunoassays
6.3. Fluorescence Immunoassays
6.4. Colorimetric Immunoassays
6.5. Radioimmunoassays
6.6. Other Immunoassay Platforms

7. Global Immunoassay Market, by Application
7.1. Overview
7.2. Infectious Diseases
7.3. Cardiology
7.4. Endocrinology
7.5. Oncology
7.6. Bone and Mineral Diseases
7.7. Autoimmune Disease
7.8. Allergy
7.9. Other Applications

8. Global Immunoassay Market, by End User
8.1. Overview
8.2. Hospitals and Clinics
8.3. Clinical Laboratories
8.4. Blood Banks
8.5. Pharmaceutical and Biotechnology Companies
8.6. Academic & Research Institutions
8.7. Other End Users
Click Here to Get Complete TOC

To Purchase This Report, Click here:

Contact Info:
Name: Khushal
Email: Send Email
Organization: Meticulous Research®
Address: Pune, India
Phone: +91 744-7780008

Release ID: 88942756